| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $115K | -81.6% | — |
| R&D Expense | $2.7M | +26.7% | +70.8% |
| SG&A Expense | $768K | -13.8% | -26.5% |
| Operating Income | -$3.4M | -39.8% | -27.8% |
| Pre-tax Income | -$3.2M | -44.5% | -43.6% |
| Income Tax | $200 | — | — |
| Net Income | -$3.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.9M | -35.5% | +4.2% |
| Current Assets | $15.9M | -13.5% | -22.3% |
| Total Assets | $16.1M | -13.5% | -22.3% |
| Current Liabilities | $1.9M | +33.3% | +22.1% |
| Total Liabilities | $1.9M | +33.3% | +22.1% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$6.8M | — | — |
| Capital Expenditures | $80K | — | — |
| Investing Cash Flow | $4.3M | — | — |
| Financing Cash Flow | $217K | — | — |
| Free Cash Flow | -$6.9M | — | — |
| -43.6% |
| EPS (Basic) | -$0.59 | -43.9% | -43.9% |
| EPS (Diluted) | -$0.59 | -43.9% | -34.1% |
| $14.1M |
| -17.4% |
| -26.0% |